Organigram Names Former ICC Labs CEO to Lead International Expansion

Organigram appoints Guillermo Delmonte as President of new international division, sets ambitious plan for international expansion

MONCTON, NB, March 7, 2018 /CNW/ – Organigram Holdings Inc. (TSX VENTURE:OGI) (OTCQB:OGRMF) (the “Company” or “Organigram”), a leading licensed producer of medical marijuana based in Moncton, New Brunswick, is pleased to announce the appointment of Guillermo Delmonte as the President of its new international division. Mr. Delmonte will assume his new role effective March 8, 2017.

A proven leader in the international cannabis and CBD marketplace, Mr. Delmonte joins the Organigram team following two and a half years as Chief Executive Officer at ICC Labs Inc., a leading international hemp and cannabis producer. In this role, he successfully oversaw the ICC’s initial public offering (IPO) as the first South American cannabis company to go public with a first day valuation of more than $120 million CAD.

Guillermo is a tremendous addition to the Organigram team. His deep understanding of global markets and opportunities, track record of international leadership, and extensive network around the world are key to our international plans as we target Europe, Australia and other regions worldwide in the burgeoning cannabis and hemp marketplace.

Greg Engel, CEO, Organigram

As President of this new venture, Mr. Delmonte will lead the planning and execution of the Company’s international expansion strategy and work out of multiple locations on behalf of the Company.

Larry Rogers, Vice President of International Business Development, Organigram, will work closely with Mr. Delmonte. “Our plans for international expansion are robust and ambitious,” says Engel. “With the full force of Guillermo’s and Larry’s expertise and vision behind these efforts, we continue to build one of the strongest executive teams in the global cannabis marketplace.”

Mr. Delmonte has also held financial and business development leadership roles at companies including BBVA Bank, Technit Group, Credit Agricole Bank, United Nations Uruguay and Bank ITAU.

Mr. Delmonte is a graduate of ORT, University Montevideo (Uruguay), Institut d’Estudis Financiers Barcelona (Spain), and IEEM Montevideo University (Uruguay).

For more information, visit www.Organigram.ca

About Organigram Holdings Inc.

Organigram Holdings Inc. is a TSX Venture Exchange listed company whose wholly owned subsidiary, Organigram Inc., is a licensed producer of medical marijuana in Canada. Organigram is focused on producing the highest quality, condition specific medical marijuana for patients in Canada. Organigram’s facility is located in Moncton, New Brunswick and the Company is regulated by the Access to Cannabis for Medical Purposes Regulations (“ACMPR”).

Original press release

Before this cannabis stock news is here, it’s published to subscribers on 420 Investor.

Published by NCV Newswire
NCV Newswire
The NCV Newswire by New Cannabis Ventures aims to curate high quality content and information about leading cannabis companies to help our readers filter out the noise and to stay on top of the most important cannabis business news. The NCV Newswire is hand-curated by an editor and not automated in anyway. Have a confidential news tip? Get in touch.

Get Our Sunday Newsletter